Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 52.46M | 50.86M | 49.02M | 47.87M | 46.11M |
| Total Other Revenue | 475.00K | 302.00K | 438.00K | 186.00K | 376.00K |
| Total Revenue | 52.94M | 51.17M | 49.46M | 48.05M | 46.49M |
| Cost of Revenue | 16.40M | 16.34M | 15.96M | 16.17M | 15.62M |
| Gross Profit | 36.54M | 34.83M | 33.49M | 31.88M | 30.86M |
| SG&A Expenses | 27.72M | 25.00M | 24.69M | 26.44M | 18.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.35M | 48.19M | 46.75M | 49.17M | 39.85M |
| Operating Income | 1.58M | 2.98M | 2.70M | -1.11M | 6.63M |
| Income Before Tax | 2.46M | 2.86M | 2.95M | -878.00K | 2.18M |
| Income Tax Expenses | 2.29M | 904.00K | 401.00K | -117.00K | 1.28M |
| Earnings from Continuing Operations | 172.00K | 1.96M | 2.55M | -761.00K | 900.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.00K | -542.00K | -721.00K | 222.00K | -277.00K |
| Net Income | 121.00K | 1.42M | 1.83M | -539.00K | 623.00K |
| EBIT | 1.58M | 2.98M | 2.70M | -1.11M | 6.63M |
| EBITDA | 3.33M | 4.54M | 4.38M | 461.00K | 9.15M |
| EPS Basic | 0.00 | 0.02 | 0.02 | -0.01 | 0.01 |
| Normalized Basic EPS | 0.02 | 0.01 | 0.01 | 0.00 | 0.04 |
| EPS Diluted | 0.00 | 0.02 | 0.02 | -0.01 | 0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.00 | 0.03 |
| Average Basic Shares Outstanding | 94.26M | 92.90M | 91.48M | 89.51M | 88.28M |
| Average Diluted Shares Outstanding | 129.56M | 128.98M | 128.85M | 89.51M | 127.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |